X
    アカデミックビジュアライゼーションスタジオRC   ログイン (EN)   原稿を依頼する (EN)
学術英語編集

Neurology and Therapy

ジャーナルタイトルで検索 NEUROL THER 最新のコメント: お尋ねしますが、後ろはどうなりましたか? (2024-09-16)


ジャーナル名:   ISSN:   主題分野:   インパクトファクタ範囲: -
インデックス:   カテゴリー:   オープンアクセス:   Sort by:

[Neurology and Therapy]こんにちは、このページの訪問者は7785番目です。

ジャーナル プロフィール
ジャーナル タイトルNeurology and Therapy Neurology and Therapy
LetPub Score
8.0
50 ratings
Rate

Reputation
9.8

Influence
6.8

Speed
7.1

ジャーナルの略称NEUROL THER
ISSN2193-8253
E-ISSN2193-6536
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.401.0421.049
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Neurology (clinical)
Q2134 / 400
Category: Medicine
Subcategory: Neurology
Q267 / 192

自己引用率 (2023-2024)5.10%自己引用率トレンド
掲載範囲
Aims and Scope

Neurology and Therapy aims to provide reliable and inclusive, rapid publication for all therapy related research for neurological indications, supporting the timely dissemination of research with a global reach, to help advance scientific discovery and support clinical practice.

Neurology and Therapy is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of neurological and psychiatric therapies, (also covering surgery and devices). Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, trial designs, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Neurology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

Rapid Publication

The journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted, it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model, this allows for the rapid and efficient communication of the latest research and reviews to support scientific discovery and clinical practice.



Open Access

All articles published by Neurology and Therapy are open access.



Personal Service

The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts.



Digital Features and Plain Language Summaries

Neurology and Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.



For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/



Publication Fees

Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5250/$6000/£4300. The journal will consider fee discounts and waivers for developing countries and this is decided on a case-by-case basis.

Peer Review Process

Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials and Letters which are generally reviewed by one member of the Editorial Board. Where reviews conflict, an Editorial Board Member will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed. Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised, it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor, and authors are welcome to make rebuttals against individual reviewer comments, if appropriate.



Preprints

We encourage posting of preprints of primary research manuscripts on preprint servers, authors' or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals.

Please see here for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550



Copyright

Neurology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.



Contact

For more information about the journal, including pre-submission enquiries, please contact managing editor Lydia Alborn at lydia.alborn@springer.com.

公式サイトhttps://www.springer.com/40120
オンライン原稿提出https://www.editorialmanager.com/neth
オープンアクセスYes
出版社SPRINGER LONDON LTD
主題分野CLINICAL NEUROLOGY
出版国/地域ENGLAND
発行頻度年4回刊行
発行開始年0
年間記事数106年間記事数トレンド
ゴールド OA 割合99.31%
OA Related Info
APC: Yes( EUR5500; USD6850; GBP4700; )
APC waiver:Check Notes
Other charges: No
Keywords: neurology、psychiatry
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CLINICAL NEUROLOGYSCIEQ154/277
インデックス (SCI or SCIE)Science Citation Index Expanded
PubMed Central (PMC) へのリンクhttps://www.ncbi.nlm.nih.gov/nlmcatalog?term=2193-8253%5BISSN%5D
平均査読期間 *出版社からの許可を得たデータ:
著者からのデータ: 6 Weeks
競争力 *著者からのデータ:
参考になるリンク
関連するジャーナル 【Neurology and Therapy】CiteScoreトレンド
自己引用率トレンド 年間記事数トレンド
著者のコメント
*すべてのレビュープロセスの指標、例えば受理率やレビューの速さは、ユーザーが提出した原稿に限定されています。そのため、これらの指標はジャーナルの正確な競争力や速さを反映していない可能性があります。
  • 同じ学問分野のジャーナル
  • CiteScoreトレンド
  • 自己引用率トレンド
  • 年間記事数トレンド
  •  
    学問分野内の信頼できるジャーナル インパクトファクター
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    学問分野内で最も検索されたジャーナル ページビュー
    BIOMATERIALS712504
    MEDICINE651739
    JOURNAL OF ETHNOPHARMACOLOGY529242
    Frontiers in Pharmacology517387
    BIOMEDICINE & PHARMACOTHERAPY499545
    Journal of Materials Chemistry B476446
    Frontiers in Immunology466168
    COMPUTERS IN BIOLOGY AND MEDICINE426091
    COLLOIDS AND SURFACES B-BIOINTERFACES420348
    Frontiers in Oncology419818
  •  

    Neurology and Therapy Neurology and Therapy
    来年の予測:
    着実な増加 変化なし 徐々に減少  更新する
  •  

     
  •  

     


最初    前へ    1    次へ    最後  (ページ
/1)
  [Neurology and Therapy] のレビューレビューを書く
著者: 小魏医师


分野: 医学
査読期間: 0.0 month(s)
結果: 保留中&不明


レビューを書く

2024-09-16 21:00:17 レビューした
お尋ねしますが、後ろはどうなりましたか?
(1) いいね! | 小魏医师

著者: undefined


分野: 医学
査読期間: 1.0 month(s)
結果: 保留中&不明


レビューを書く

2024-01-14 03:03:32 レビューした
2023年12月5日 提出
2023年12月12日 審査中
2023年12月21日 審査中
2023年12月28日 軽微な遅延
2024年1月12日 必要な審査完了
(0) いいね! | undefined

著者: lijian0926


分野: 医学
査読期間: 1.0 month(s)
結果: 改訂後に受け入れられました


レビューを書く

2023-09-14 21:14:19 レビューした
8月14日に投稿され、9月13日に承認され、その間に細かい修正が一度入りましたが、比較的スピーディーな進行でした
(0) いいね! | lijian0926

最初    前へ    1    次へ    最後  (ページ
/1)

[Neurology and Therapy] のレビューを書き始める:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*

>